Lu Chen
Impact in
- Oncology top 2%
- Lymphatic System and Diseases
- Global Cancer Incidence and Screening
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- RNA modifications and cancer 12
- Circular RNAs in diseases 6
- Oncology 30
- CAR-T cell therapy research 7
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Czeslaw Radziejewski (1 shared paper)M. Reza Dana (1 shared paper)David G. Jackson (1 shared paper)Stanley J. Wiegand (1 shared paper)Patrìcia A. D'Amore (1 shared paper)Jingtai Cao (1 shared paper)J. Wayne Streilein (1 shared paper)Claus Cursiefen (1 shared paper)
- Journals
- Blood (6 papers)Journal of Clinical Oncology (3 papers)Journal of Neuroscience (3 papers)PLoS ONE (2 papers)European Journal of Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Lu Chen
132 papers receiving 3.5k citations
Lu Chen's Hit Papers
Peers
Comparison fields: 5 of 146
- Oncology 876
- Cancer Research 422
- Immunology 392
- Pathology and Forensic Medicine 290
- Neurology 131
Countries citing papers authored by Lu Chen
This map shows the geographic impact of Lu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Chen more than expected).
Fields of papers citing papers by Lu Chen
This network shows the impact of papers produced by Lu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Chen. The network helps show where Lu Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 143 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment Hit paper breakdown → | 2004 | 877 |
| 2 | 2015 | 124 | |
| 3 | 2021 | 119 | |
| 4 | 2010 | 95 | |
| 5 | 2006 | 90 | |
| 6 | 2020 | 87 | |
| 7 | 2017 | 70 | |
| 8 | 2013 | 66 | |
| 9 | 2015 | 65 | |
| 10 | 2016 | 65 | |
| 11 | 2014 | 64 | |
| 12 | 2014 | 64 | |
| 13 | 2013 | 63 | |
| 14 | 2016 | 61 | |
| 15 | 2023 | 57 | |
| 16 | 2021 | 56 | |
| 17 | 2020 | 46 | |
| 18 | 2013 | 45 | |
| 19 | 2005 | 45 | |
| 20 | 2014 | 44 |
About Lu Chen
Lu Chen is a scholar working on Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine and Surgery, having authored 143 papers that have together received 3.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (13 papers), RNA modifications and cancer (12 papers), MicroRNA in disease regulation (11 papers), CAR-T cell therapy research (7 papers), Circular RNAs in diseases (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Neuroscience of respiration and sleep (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Oncology (876 citations), Cancer Research (422 citations), Immunology (392 citations), Pathology and Forensic Medicine (290 citations) and Neurology (131 citations). Lu Chen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Czeslaw Radziejewski, M. Reza Dana, David G. Jackson, Stanley J. Wiegand, Patrìcia A. D'Amore, Jingtai Cao, J. Wayne Streilein, Claus Cursiefen, Christopher I. Li and Xiang Yang Chen. Their work appears in journals such as Blood, Journal of Clinical Oncology, Journal of Neuroscience, PLoS ONE and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.